Mesenchymal Stem/Stromal Cell Therapeutic Features: The Bridge between the Bench and the Clinic

Makram Merimi^{1

2}, Philippe Lewalle¹, Nathalie Meuleman¹, Douâa Moussa Agha¹, Hoda El-Kehdy³, Fatima Bouhtit^{1

2}, Sara Ayoub⁴, Arsène Burny⁵, Hassan Fahmi⁶, Laurence Lagneaux⁷, Mehdi Najar^{6

7}

Affiliations

¹ Laboratory of Experimental Hematology, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Bruxelles, Belgium.
² Genetics and Immune Cell Therapy Unit, LBBES Laboratory, Faculty of Sciences, University Mohammed Premier, Oujda 60000, Morocco.
³ Laboratory of Pediatric Hepatology and Cell Therapy, UCLouvain, Institut de Recherche Expérimentale et Clinique, 1200 Brussels, Belgium.
⁴ Department of Prosthodontics, Faculty of Dental Medicine, Lebanese University, Hadath, 10999 Beirut, Lebanon.
⁵ Laboratory of Molecular and Cellular Biology, Faculté Universitaire des Sciences Agronomiques de Gembloux, 5030 Gembloux, Belgium.
⁶ Osteoarthritis Research Unit, University of Montreal Hospital Research Center, Montreal, QC H2X 0A9, Canada.
⁷ Laboratory of Clinical Cell Therapy, Institut Jules Bordet, Université Libre de Bruxelles, 1070 Brussels, Belgium.

Editorial

Makram Merimi et al. J Clin Med. 2021.

. 2021 Feb 25;10(5):905.

doi: 10.3390/jcm10050905.

¹ Laboratory of Experimental Hematology, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Bruxelles, Belgium.
² Genetics and Immune Cell Therapy Unit, LBBES Laboratory, Faculty of Sciences, University Mohammed Premier, Oujda 60000, Morocco.
³ Laboratory of Pediatric Hepatology and Cell Therapy, UCLouvain, Institut de Recherche Expérimentale et Clinique, 1200 Brussels, Belgium.
⁴ Department of Prosthodontics, Faculty of Dental Medicine, Lebanese University, Hadath, 10999 Beirut, Lebanon.
⁵ Laboratory of Molecular and Cellular Biology, Faculté Universitaire des Sciences Agronomiques de Gembloux, 5030 Gembloux, Belgium.
⁶ Osteoarthritis Research Unit, University of Montreal Hospital Research Center, Montreal, QC H2X 0A9, Canada.
⁷ Laboratory of Clinical Cell Therapy, Institut Jules Bordet, Université Libre de Bruxelles, 1070 Brussels, Belgium.

Abstract

Mesenchymal stem/stromal cells (MSCs) are considered a relevant therapeutic product for various clinical applications [...].

The authors declare that they have no conflicts of interest.

1. Wobma H., Satwani P. Mesenchymal stromal cells: Getting ready for clinical primetime. Transfus. Apher. Sci. 2021;11:103058. doi: 10.1016/j.transci.2021.103058. - DOI - PubMed
1. Girousse A., Mathieu M., Sastourné-Arrey Q., Monferran S., Casteilla L., Sengenès C. Endogenous Mobilization of Mesenchymal Stromal Cells: A Pathway for Interorgan Communication? Front. Cell Dev. Biol. 2021;8:1534. doi: 10.3389/fcell.2020.598520. - DOI - PMC - PubMed
1. Liu Q.W., Huang Q.M., Wu H.Y., Zuo G.S., Gu H.C., Deng K.Y., Xin H.B. Characteristics and Therapeutic Potential of Human Amnion-Derived Stem Cells. Int. J. Mol. Sci. 2021;22:970. doi: 10.3390/ijms22020970. - DOI - PMC - PubMed
1. Miceli V., Bulati M., Iannolo G., Zito G., Gallo A., Conaldi P.G. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine. Int. J. Mol. Sci. 2021;22:763. doi: 10.3390/ijms22020763. - DOI - PMC - PubMed
1. Samal J.R.K., Rangasami V.K., Samanta S., Varghese O.P., Oommen O.P. Discrepancies on the Role of Oxygen Gradient and Culture Condition on Mesenchymal Stem Cell Fate. Adv. Healthc. Mater. 2021:e2002058. doi: 10.1002/adhm.202002058. - DOI - PMC - PubMed